More such party convention will be organised in North Karnataka, says Minister
Speaking to presspersons in Haveri on Wednesday, Mr. Patil said that similar party convention will be held in North Karnataka also.
He said that Chief Minister Siddaramaiah has already said that he will be the Chief Minister for the whole tenture and he will not comment on it.
On the allegation of corruption in supply of milk power to anganwadi centres in Haveri, he said that at the outset it appears to be no scam but he will get it inquired.
On the alleged illegal appointment of medical college staff, the Minister said that he has already spoken to the dean concerned on the issue and it appears to be because of technical issues. But if any illegality is found, action will be taken, he said.
On the supply of fertilisers, he said that the Centre is not supplying adequate quantity of urea to the State as there is huge demand because of copious rainfall.
'Already, four cases have been filed against supply of poor quality fertiliser. Their licence has been cancelled and steps will be taken to arrest sellers of spurious fertiliser,' he said.
'No increase'
Replying to a query, Medical Education Minister Sharanprakash Patil clarified that there has been no increase in the number of deaths due to heart attacks in the last six months. 'People have been given wrong information. We have inquired into the issue and it is clear that deaths are not due to COVID-19 vaccine,' he said.
To another query, he said that the Haveri medical college will soon get cardiologists and also a hi-tech MRI scan centre.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
an hour ago
- The Hindu
Patients struggle as MRI and mammogram machines break down at State-run Kidwai Memorial Institute of Oncology
Scores of cancer patients visiting the State-run Kidwai Memorial Institute of Oncology are facing long delays in diagnosis and treatment as the hospital's MRI and mammogram machines have been out of order for days. As a result, patients are left with no choice but to wait or seek costly alternatives elsewhere. The MRI scanner, crucial for diagnosing and monitoring tumors, reportedly broke down ten days ago, while the mammogram machine — vital for breast cancer screening — has been non-functional for over a fortnight, according to hospital staff. Patients and their families, many of whom travel from rural areas and depend on the subsidised services at Kidwai, said they cannot afford private diagnostic centers where the cost of an MRI or mammogram can run into thousands of rupees. 'I came here three days ago for my scan, and they told me the machine is not working. They asked me to come back after a week, but I cannot stay in Bengaluru for very long. Where will I go?' asked a 47-year-old breast cancer patient from Mandya district. Sources said that the breakdown has caused severe bottlenecks. 'We are trying to prioritise urgent cases. The repairs are taking longer than expected,' a doctor said. Alternate arrangements The hospital officials acknowledged the problem and said that tenders for repair and maintenance are under way. 'The MRI and mammogram machines are undergoing repair due to technical issues. To ensure that diagnostic services continue without disruption, alternative arrangements have been made,' said an official statement from the institute director. 'MRI scans are now being facilitated at NIMHANS and Sanjay Gandhi Institute of Trauma and Orthopaedics, based on a formal agreement (MoU) with these institutions. Patients admitted at Kidwai are being referred and provided the necessary diagnostic support at these centres,' the statement said. The State government has approved the procurement of a new MRI machine, and steps are under way to repair the existing mammogram machine, it added.
The Hindu
an hour ago
- The Hindu
V-C hails critical role of nurses, paramedics in healthcare domain
P. Prakash Babu, Vice-Chancellor of Pondicherry University, has underscored the critical role of nurses and paramedics in the healthcare system. Addressing the recent graduation ceremony at Sri Venkateshwaraa Medical College, an affiliate institution of the University, the Vice-Chancellor told the graduating class of paramedics, nurses, physiotherapists, and allied health professionals that their role in the field of healthcare went beyond just supporting doctors. 'You are the backbone of the healthcare system. You are the first to respond in emergencies, the steady hand in recovery, and the kind voice in moments of fear. Whether it's a nurse offering comfort in a crowded hospital ward, a physiotherapist helping someone walk again after injury, or a lab technician ensuring accurate diagnoses — your work changes lives', Mr. Prakash Babu said. Recalling the vital roles of these health professionals in times of public health crises like the COVID-19 pandemic, he said: 'The world has finally begun to see what we have always known: that healthcare is not possible without paramedics and allied professionals. Dwelling on the theme of 'Viksit Bharat - 2047: Role of Paramedics in India', Mr. Babu said achieving the set goals required robust progress in various sectors, and healthcare stands as a cornerstone. Within the healthcare system, paramedics — including nursing staff, emergency medical technicians (EMTs), lab technicians, radiographers, and other allied health professionals — have a critical role in strengthening the healthcare delivery system, expanding accessibility and affordability and ensuring a continuum of care. The Vice-Chancellor also stressed the vital role of paramedics in emergency and disaster response, mass casualty management, crisis containment, propagation of digital health and telemedicine support and supporting preventive and primary care. Their mandate, which includes conducting awareness programmes, vaccination drives, screenings (BP, diabetes, malnutrition), and home visits, is key to reducing long-term national health costs and also reducing urban-rural health disparities, he said. According to the Vice-Chancellor, as India focuses on strengthening healthcare infrastructure — from metros to remote villages — the need for skilled, ethical, and compassionate paramedics has never been greater. 'You are entering a field where your degree is not just a qualification; it is a responsibility. A responsibility to serve with empathy, to uphold the dignity of life, and to continue learning every day', he said. The Vice-Chancellor also conferred degrees upon the graduating students. B. Ramachandiran, chairman, Radha Ramachandiran, Founder Trustee, Rajiv Krishna, Managing Director, Sree Venkateshwaraa Group of Institutions (SVGI), Moushmi Rajiv, Executive Director, SVGI, B. Vidhya Rangaraju, Chief Operating Officer, Malliga Kannan, Principal Indirani College of Nursing, C. Ananda Vayaravel Cassinadane, Dean, College of Paramedical Sciences and S. Jeyanthi, Principal, College of Physiotherapy were present.
Time of India
5 hours ago
- Time of India
RFK Jr. and other Trump officials embrace psychedelics after FDA setback
Washington: For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering substances like LSD and ecstasy should be approved for Americans grappling with depression, trauma and other hard-to-treat conditions. A presidential administration finally seems to agree. "This line of therapeutics has tremendous advantage if given in a clinical setting and we are working very hard to make sure that happens within 12 months," Health Secretary Robert F. Kennedy Jr. recently told members of Congress. His suggested timeline for green-lighting psychedelic therapy surprised even the most bullish supporters of the drugs. And it comes as psychedelics are making inroads in deep red states like Texas, where former Trump cabinet secretary and ex-governor Rick Perry has thrown his full support behind the effort. The administration's embrace of psychedelics has sparked both excitement as well as concern from those in the field, who worry the drugs might be discredited if they appear to be rushed onto the market or are too closely linked with Kennedy, who is known for controversial views on vaccines, antidepressants and fluoride. "I'm quite optimistic," says Rick Doblin, whose organization has pursued the medical use of MDMA (or ecstasy) since the 1980s. "But I'm also worried that the message the public might get is 'Well, RFK likes psychedelics and now it's approved.'" FDA may reconsider MDMA Under President Joe Biden, the FDA rejected MDMA as a treatment for post-traumatic stress disorder, citing flawed data and questionable research. Regulators called for a new study, likely taking several years. It was a major setback for Doblin and other advocates hoping to see the first U.S. approval of a psychedelic for medical use. But the agency appears ready to reconsider. FDA chief Marty Makary, who reports to Kennedy, has called the evaluation of MDMA and other psychedelics "a top priority," announcing a slate of initiatives that could be used to accelerate their approval. One new program promises to expedite drugs that serve "the health interests of Americans," by slashing their review time from six months or more to as little as one month. Makary has also suggested greater flexibility on requirements for certain drugs, potentially waiving rigorous controlled studies that compare patients to a placebo group. That approach, considered essential for high-quality research, has long been a stumbling point for psychedelic studies, in which patients can almost always correctly guess whether they've received the drug or a dummy pill. The U.S. Department of Health and Human Services and FDA also recently hired several new staffers with ties to the psychedelic movement. "These are all very promising signs that the administration is aware of the potential of psychedelics and is trying to make overtures that they're ready to approve them," said Greg Ferenstein, a fellow at the libertarian Reason Foundation, who also consults for psychedelic companies. "We didn't hear anything about that in the Biden administration" A spokesperson for HHS did not respond to a request for comment. As a presidential candidate, Kennedy discussed how his son and several close friends benefited from using psychedelics to deal with grief and other issues. A number of veterans lobbying for psychedelic access have already met with Trump's Secretary of Veterans Affairs, Doug Collins. "What we're seeing so far is positive," Collins told House lawmakers in May. But some experts worry the hope and hype surrounding psychedelics has gotten ahead of the science. Philip Corlett, a psychiatric researcher at Yale University, says bypassing rigorous clinical trials could set back the field and jeopardize patients. "If RFK and the new administration are serious about this work, there are things they could do to shepherd it into reality by meeting the benchmarks of medical science," Corlett said. "I just don't think that's going to happen." Texas goes all-in on ibogaine research As officials in Washington weigh the future of psychedelics, some states are moving ahead with their own projects in hopes of nudging the federal government. Oregon and Colorado have legalized psychedelic therapy. And last month, Texas approved $50 million to study ibogaine, a potent psychedelic made from a shrub that's native to West Africa, as a treatment for opioid addiction, PTSD and other conditions. The research grant - the largest of its kind by any government - passed with support from the state's former GOP governor, Perry, and combat veterans, some who have traveled to clinics in Mexico that offer ibogaine. Ibogaine is on the U.S. government's ultra-restrictive list of illegal, Schedule 1 drugs, which also includes heroin. So advocates in Texas are hoping to build a national movement to ease restrictions on researching its use. "Governmental systems move slowly and inefficiently," said Bryan Hubbard of Americans for Ibogaine, a group formed with Perry. "Sometimes you find yourself constrained in terms of the progress you can make from within." Ibogaine is unique among psychedelics in both its purported benefits and risks. Small studies and anecdotal reports suggest the drug may be able to dramatically ease addiction and trauma. It was sold for medical use in France for several decades starting in the 1930s, but the drug can also cause dangerous irregular heart rhythms, which can be fatal if left untreated. Some veterans who have taken the drug say the risks can be managed and ibogaine's healing properties go far beyond antidepressants, mood stabilizers, counseling and other standard treatments. Marcus Capone struggled with anger, insomnia and mood swings after 13 years as a Navy Seal. In 2017, at the urging of his wife Amber, he agreed to try ibogaine as a last resort. He described his first ibogaine session as "a complete purge of everything." "But afterward I felt the weight just completely off my shoulders," he said. "No more anxiety, no more depression, life made sense all of a sudden." A nonprofit founded by the Capones, Veterans Exploring Treatment Solutions, or VETS, has helped over 1,000 veterans travel abroad to receive ibogaine and other psychedelics. But federal scientists have looked at the drug before - three decades ago, when the National Institute on Drug Abuse funded preliminary studies on using it as an addiction treatment. The research was discontinued after it identified "cardiovascular toxicity." "It would be dead in the water," in terms of winning FDA approval, longtime NIDA director Nora Volkow said. But Volkow said her agency remains interested in psychedelics, including ibogaine, and is funding an American drugmaker that's working to develop a safer, synthetic version of the drug. "I am very intrigued by their pharmacological properties and how they are influencing the brain," Volkow said. "But you also have to be very mindful not to fall into the hype and to be objective and rigorous in evaluating them."
